Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michio Sata

Showing results (161-170 of 416) with videos related to

Pageof 42
Sort By:
Digestive Diseases and Sciences|April 24, 2004
Adefovir dipivoxil as a treatment for hepatic failure caused by lamivudine-resistant HBV strainsReiichiro Kuwahara, Ryukichi Kumashiro, Hiroto Inoue, et al.
BMC Cancer|December 21, 2006
Cell cycle regulation by the Wee1 inhibitor PD0166285, pyrido [2,3-d] pyimidine, in the B16 mouse melanoma cell lineOsamu Hashimoto, Masako Shinkawa, Takuji Torimura, et al.
International Journal of Molecular Medicine|February 14, 2013
Microarray analyses of peripheral whole blood cells from ulcerative colitis patients: effects of leukocytapheresisTeppei Kobayashi, Keiichi Mitsuyama, Hiroshi Yamasaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 26, 2013
Radiofrequency ablation combined with transarterial chemoembolization for intermediate hepatocellular carcinomaMasatoshi Tanaka, Eiji Ando, Shigeo Simose, et al.
Nutrition and Cancer|September 17, 2013
Methylated-(3'')-epigallocatechin gallate analog suppresses tumor growth in Huh7 hepatoma cells via inhibition of angiogenesisOsamu Hashimoto, Anna Nakamura, Toru Nakamura, et al.
Intervirology|July 5, 2014
Characteristics and outcomes of HCV genotype-1-infected patients treated with peginterferon and ribavirin combination therapy with discordant HCV responses 4 and 12 weeks after starting therapyHidenori Toyoda, Takashi Kumada, Noritomo Shimada, et al.
Intervirology|December 23, 2003
Subclones of drug-resistant hepatitis B virus mutants and the outcome of breakthrough hepatitis in patients treated with lamivudineRyukichi Kumashiro, Reiichiro Kuwahara, Tatsuya Ide, et al.
Diabetes Research and Clinical Practice|June 30, 2004
Intermittent and recurrent hepatomegaly due to glycogen storage in a patient with type 1 diabetes: genetic analysis of the liver glycogen phosphorylase gene (PYGL)Masako Tomihira, Eiji Kawasaki, Hiromu Nakajima, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 13, 2005
Identification of hepatitis C virus 1b-derived peptides recognized by both cellular and humoral immune systems in HCV1b(+) HLA-A24(+) patientsMayumi Tamura, Akira Yamada, Yukari Takao, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|October 18, 2005
Bifidogenic growth stimulator for the treatment of active ulcerative colitis: a pilot studyAsuka Suzuki, Keiichi Mitsuyama, Hironori Koga, et al.
Pageof 42

Showing results (161-170 of 416) with videos related to

Sort By:
Pageof 42
Digestive Diseases and Sciences|April 24, 2004
Adefovir dipivoxil as a treatment for hepatic failure caused by lamivudine-resistant HBV strainsReiichiro Kuwahara, Ryukichi Kumashiro, Hiroto Inoue, et al.
BMC Cancer|December 21, 2006
Cell cycle regulation by the Wee1 inhibitor PD0166285, pyrido [2,3-d] pyimidine, in the B16 mouse melanoma cell lineOsamu Hashimoto, Masako Shinkawa, Takuji Torimura, et al.
International Journal of Molecular Medicine|February 14, 2013
Microarray analyses of peripheral whole blood cells from ulcerative colitis patients: effects of leukocytapheresisTeppei Kobayashi, Keiichi Mitsuyama, Hiroshi Yamasaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 26, 2013
Radiofrequency ablation combined with transarterial chemoembolization for intermediate hepatocellular carcinomaMasatoshi Tanaka, Eiji Ando, Shigeo Simose, et al.
Nutrition and Cancer|September 17, 2013
Methylated-(3'')-epigallocatechin gallate analog suppresses tumor growth in Huh7 hepatoma cells via inhibition of angiogenesisOsamu Hashimoto, Anna Nakamura, Toru Nakamura, et al.
Intervirology|July 5, 2014
Characteristics and outcomes of HCV genotype-1-infected patients treated with peginterferon and ribavirin combination therapy with discordant HCV responses 4 and 12 weeks after starting therapyHidenori Toyoda, Takashi Kumada, Noritomo Shimada, et al.
Intervirology|December 23, 2003
Subclones of drug-resistant hepatitis B virus mutants and the outcome of breakthrough hepatitis in patients treated with lamivudineRyukichi Kumashiro, Reiichiro Kuwahara, Tatsuya Ide, et al.
Diabetes Research and Clinical Practice|June 30, 2004
Intermittent and recurrent hepatomegaly due to glycogen storage in a patient with type 1 diabetes: genetic analysis of the liver glycogen phosphorylase gene (PYGL)Masako Tomihira, Eiji Kawasaki, Hiromu Nakajima, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 13, 2005
Identification of hepatitis C virus 1b-derived peptides recognized by both cellular and humoral immune systems in HCV1b(+) HLA-A24(+) patientsMayumi Tamura, Akira Yamada, Yukari Takao, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|October 18, 2005
Bifidogenic growth stimulator for the treatment of active ulcerative colitis: a pilot studyAsuka Suzuki, Keiichi Mitsuyama, Hironori Koga, et al.
Pageof 42